Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection

NCT00001763 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Mycobacterium Avium-Intracellulare Infection

Interventions

DRUG: Interleukin-12

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)